Even though in both trials they are targeting wnt pathway, they're doing it with completely different molecules and consequently in different ways.
Think about RU and CB, the working principle is the same but CB seems to have a much better safety profile.
All the questions will be answered in roughly two months, but even now i think it's wrong to associate side effects of two different molecules in two different parts of the body just because they both target wnt pathway.
Maybe we will have a perfectly safe drug, maybe it will cause cardiac arrest, we don't know yet, but believe me, both efficacy and side effects have nothing to do with other drugs in samumed's pipeline.